相关实验视频

Updated: Jun 29, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

低血清炎与免疫检查点抑制剂的相关性使用:通过FDA药监数据库获得洞察力

Qirui Tang¹, Yaru Han², Min Song³

¹Clinical School of Medicine, Jining Medical University, Jining, China.

|March 29, 2024

概括

免疫检查点抑制剂 (ICI) 如伊皮利穆马布,尼沃卢马布,布罗利祖马布和阿特佐利祖马布与低血压炎有关. 早期识别和管理这种不良事件对于患者的生活质量至关重要.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药物监督药物监督药物监督

背景情况:

免疫检查点抑制剂 (ICI) 彻底改变了癌症治疗,但可以引起与免疫相关的不良事件 (irAEs).
低血球炎是一种已知的irAE,可能会影响患者的生活质量.

研究的目的:

使用FDA FAERS数据库调查特定ICI和低血位炎之间的关联.
量化尼沃卢马布,潘布罗利祖马布,伊皮利穆马布和阿特佐利祖马布的低血压炎风险.

主要方法:

从FDA FAERS数据库 (Q1 2004Q2 2021) 中分析皮炎不良事件报告.
使用报告几率比率 (ROR) 方法来评估四种ICI的阴囊炎信号.
根据事件计数 (≥3) 和ROR (95% CI > 1) 定义的阳性低血球炎信号.

主要成果:

在四个ICI中,共确定了1252起低炎病例.
所有四种ICI都显示出与低体质炎的统计学显著相关性.
低血炎风险的下降顺序是伊皮利穆马布,尼沃卢马布,潘布罗利祖马布和阿特佐利祖马布.

结论:

尼沃卢马布,潘布罗利祖马布,伊皮利穆马布和阿特佐利祖马布都与缺血症有关.
早期检测和管理ICI相关的低血清炎对于减轻对生活质量的负面影响至关重要.

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.